White label ELPA - ClinicalTrials.eu

Study on Encorafenib, Cetuximab, and FOLFIRI for Patients with BRAF V600E Mutated Metastatic Colorectal Cancer After Progression on Encorafenib and Cetuximab

Not recruiting

2 1 1 1
Investigated diseases:
- Colorectal adenocarcinoma
Investigated drugs:
Study Comparing Nivolumab, Nivolumab with Ipilimumab, or Chemotherapy for Patients with Metastatic Colorectal Cancer with High Microsatellite Instability

Not recruiting

3 1 1 1
Investigated diseases:
- Colorectal cancer metastatic
Investigated drugs:
+6
A Phase 4 Study of Crizanlizumab Treatment for Patients with Sickle Cell Disease Who Previously Participated in Novartis Clinical Trials

Not recruiting

3 1 1
Investigated drugs:
- Crizanlizumab
Study on Baxdrostat for Lowering Blood Pressure in Patients with Resistant Hypertension

Not recruiting

3 1
Investigated diseases:
- Hypertension
Investigated drugs:
- Baxdrostat
+3
Study on Axatilimab for Patients with Idiopathic Pulmonary Fibrosis

Not recruiting

2 1
Investigated diseases:
- Idiopathic pulmonary fibrosis
Investigated drugs:
- Axatilimab
+2
Study of Tamibarotene, Venetoclax, and Azacitidine for Adults with RARA-positive Acute Myeloid Leukemia Not Eligible for Standard Therapy

Not recruiting

2 1 1 1
Investigated diseases:
- Acute myeloid leukaemia
Investigated drugs:
Study on the Safety and Effectiveness of Dexlansoprazole for Treating Nonerosive GERD in Children Aged 2 to 11 Years

Not recruiting

2 1 1
Investigated diseases:
- Gastrooesophageal reflux disease
Investigated drugs:
- Dexlansoprazole
Study on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Moderate-to-Severe Plaque Psoriasis

Not recruiting

3 1
Investigated diseases:
- Psoriasis
Investigated drugs:
- Deucravacitinib
+2
Study on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment

Not recruiting

3 1 1 1
Investigated diseases:
- Bladder transitional cell carcinoma
Investigated drugs:
- Cetrelimab
- Gemcitabine Hydrochloride
+3
Study on Dexlansoprazole for Treating and Maintaining Healing of Erosive Esophagitis in Children Aged 2 to 11 Years

Not recruiting

2 1 1
Investigated diseases:
- Erosive oesophagitis
Investigated drugs:
- Dexlansoprazole

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies